Cargando…
Synthesis of Pseudellone Analogs and Characterization as Novel T-type Calcium Channel Blockers
T-type calcium channel (Ca(V)3.x) blockers are receiving increasing attention as potential therapeutics for the treatment of pathophysiological disorders and diseases, including absence epilepsy, Parkinson’s disease (PD), hypertension, cardiovascular diseases, cancers, and pain. However, few clinica...
Autores principales: | Wang, Dan, Neupane, Pratik, Ragnarsson, Lotten, Capon, Robert J., Lewis, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315694/ https://www.ncbi.nlm.nih.gov/pubmed/30487473 http://dx.doi.org/10.3390/md16120475 |
Ejemplares similares
-
Diindolylmethane Derivatives: New Selective Blockers for T-Type Calcium Channels
por: Wang, Dan, et al.
Publicado: (2022) -
Characterisation of δ-Conotoxin TxVIA as a Mammalian T-Type Calcium Channel Modulator
por: Wang, Dan, et al.
Publicado: (2020) -
Transfection methods for high-throughput cellular assays of voltage-gated calcium and sodium channels involved in pain
por: Hasan, Md. Mahadhi, et al.
Publicado: (2021) -
Expression and Pharmacology of Endogenous Ca(v) Channels in SH-SY5Y Human Neuroblastoma Cells
por: Sousa, Silmara R., et al.
Publicado: (2013) -
Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from Conus miliaris
por: Giribaldi, Julien, et al.
Publicado: (2020)